P48.05 Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC?
M. Garcia,S. Schmid,Katrina Hueniken,L. Zhan,K. Balaratnam,K. Khan,Aline Fusco Fares,Sze Wah Samuel Chan,Elliot Charles Smith,Reenika Aggarwal,M.C. Brown,Devalben Patel,Adrian G. Sacher,Penelope A. Bradbury,Frances A. Shepherd,Natasha B. Leighl,Geoffrey Liu Journal of Thoracic Oncology（2021）
AI 理解论文
溯源树
样例
